Simvastatin in Critically Ill Patients with COVID-19
Compared with no statin in the REMAP-CAP trial, simvastatin did not meet the prespecified criteria for superiority to control COVID-19. “We found a 95.9% probability
Compared with no statin in the REMAP-CAP trial, simvastatin did not meet the prespecified criteria for superiority to control COVID-19. “We found a 95.9% probability
Infusions of the beta-blocker landiolol did not significantly reduce organ failure in patients with septic shock and norepinephrine-treated tachycardia, compared with standard care, the STRESS-L
Patients hospitalized with COVID-19 at 130 sites on 4 continents received little benefit from intravenous vitamin C, researchers report. The authors concluded that the intervention
In the Mupirocin-Iodophor ICU Decolonization Swap Out Trial, nasal iodophor antiseptic used during daily chlorhexidine gluconate (CHG) bathing in adults in intensive care units (ICUs)
Length of stay in intensive care units (ICUs) and 90-day mortality were not significantly different with tight glucose control in critically ill patients who were
In critically ill patients, sublingual buprenorphine was as effective as oral or enteral oxycodone in terms of pain control and opioid consumption, according to a retrospective, parallel,
The focus of research on cardiogenic shock (CS) is shifting from acute myocardial infarction (AMI) to heart failure-related CS, according to authors of a review of
In a study that focused on Medicare coverage, insurance-related differences in treatment were found during the discharge planning process for otherwise similar patients with trauma,
Compared with intermittent dosing in critically ill patients, “continuous administration of meropenem did not improve the composite outcome of mortality and emergence of pandrug-resistant or
A study finds new use of sedatives in 1 of 15 older adults within 7 days of discharge and filling of persistent sedative prescriptions for